Cardiogenesis (cgcp) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiogenesis (cgcp)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Joy who wrote (11)	7/30/1997 10:45:00 AM
From: John Martin	of 66

Keep reading the news releases for PLC. PLC is still a contender. The FDA rejected PLC's application due to insufficient data. The FDA wants more information from the 12-month follow-up from the phase III trials. This information can be gathered in Sept. I would expect PLC to be applying for review again before the end of the year. The results of the rejection is good for cgcp because they now know what the FDA wants and can be prepared for it. I would expect PLC will be fully prepared next time too. John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next